Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Tang

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Nature Medicine|January 21, 2026
Nature Medicine Commission on dialysis policy in low- and middle-income countriesYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nature Medicine|January 21, 2026
The path to safe, equitable and sustainable dialysis provision for people with chronic kidney diseaseYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2010
The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetesSydney C W Tang, Violet T M Leung, Loretta Y Y Chan, et al.
American Journal of Nephrology|January 13, 2016
Screening Algorithm for BK Virus-Associated Nephropathy Using Sequential Testing of Urinary Cytology: A Probabilistic Model AnalysisMaggie K M Ma, Anskar Y H Leung, Kin Yee Lo, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|March 4, 2025
Add-on astragalus therapy for diabetic kidney disease: an open-label randomised controlled trial with responder regression analysis (abridged secondary publication)K W Chan, A S K Kwong, P N Tsui, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2021
Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A <i>Post Hoc</i> Analysis from the SONAR TrialSimke W Waijer, Sieta T de Vries, Robert Busch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2025
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in AsiaRajiv Agarwal, Masaomi Nangaku, Liming Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 5, 2024
The Hong Kong Renal Registry: a recent updateJ Y H Chan, Y L Cheng, S K Yuen, et al.
The Lancet Regional Health. Western Pacific|April 2, 2025
A 30-year case study of local implementation of global guidelines for data-driven diabetes management starting with the Hong Kong Diabetes RegisterJuliana C N Chan, Michael Cheung, Andrea O Y Luk, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Nature Medicine|January 21, 2026
Nature Medicine Commission on dialysis policy in low- and middle-income countriesYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nature Medicine|January 21, 2026
The path to safe, equitable and sustainable dialysis provision for people with chronic kidney diseaseYot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2010
The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetesSydney C W Tang, Violet T M Leung, Loretta Y Y Chan, et al.
American Journal of Nephrology|January 13, 2016
Screening Algorithm for BK Virus-Associated Nephropathy Using Sequential Testing of Urinary Cytology: A Probabilistic Model AnalysisMaggie K M Ma, Anskar Y H Leung, Kin Yee Lo, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|March 4, 2025
Add-on astragalus therapy for diabetic kidney disease: an open-label randomised controlled trial with responder regression analysis (abridged secondary publication)K W Chan, A S K Kwong, P N Tsui, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2021
Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A <i>Post Hoc</i> Analysis from the SONAR TrialSimke W Waijer, Sieta T de Vries, Robert Busch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2025
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in AsiaRajiv Agarwal, Masaomi Nangaku, Liming Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 5, 2024
The Hong Kong Renal Registry: a recent updateJ Y H Chan, Y L Cheng, S K Yuen, et al.
The Lancet Regional Health. Western Pacific|April 2, 2025
A 30-year case study of local implementation of global guidelines for data-driven diabetes management starting with the Hong Kong Diabetes RegisterJuliana C N Chan, Michael Cheung, Andrea O Y Luk, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Pageof 26